Early research (Phase 1)Study completedNCT03323034
What this trial is testing
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma
Who this might be right for
Recurrent LymphomaRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm+3 more
Children's Oncology Group 30